Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 3Lymphoid 1

Conditions

Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Endometrial Neoplasms 1

Interventions

pembrolizumab 3copanlisib 2aflibercept 2X-Rays 2Specimen Handling 2ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1temsirolimus 1selinexor 1sapanisertib 1relatlimab 1pertuzumab 1palbociclib 1osimertinib 1omipalisib 1larotrectinib 1ipatasertib 1erdafitinib 1epacadostat 1enzalutamide 1entinostat 1defactinib 1dabrafenib 1ciforadenant 1capivasertib 1binimetinib 1atezolizumab 1adavosertib 1Trastuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Diet, Ketogenic × Lymphoid × Clear all
NCT04750941 2025-03-04

Study of Copanlisib and Ketogenic Diet

Columbia University

Phase 2 Terminated
1 enrolled 9 charts
GynecologicLymphoid

Lymphoma, Follicular, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡